SHEL has now strung together three consecutive weeks of gains, adding another 1% on the week to close at £33.88 and extending its one-month advance to nearly 5% — and the story this week is less about Shell itself than about how its closest peers are splitting around it.
The peer picture is worth watching closely. BP. posted the sharpest one-day move in the group at +2.7%, but gave back ground on the week, ending down 0.4%. ENI was similarly soft over five days, off 0.2%. Shell, by contrast, held its week-on-week gain. The outperformers were further out in the peer basket: REP added 4% on the week and CNQ matched it, while EQNR and each added roughly 1%. The pattern suggests the broader energy recovery is intact, but investors are becoming more selective — Shell is holding its ground while London peer BP trails.
The lending market remains almost entirely irrelevant to the Shell thesis. Availability is extraordinarily loose — nearly 8,000% of current short interest sits unlent in the pool, meaning there are roughly 80 shares available for every one already borrowed. Cost to borrow has eased another 14% on the week to 0.48%, barely above a pure custody charge. The ORTEX short score of 35.9 has drifted slightly lower over the past ten days, and the utilization rank of 72 reflects the structural reality of a mega-cap major rather than any tactical crowding. None of this has changed materially from the note filed a week ago — bears remain entirely sidelined and there is no sign of any repositioning into the rally.
Shell's valuation anchors the bull case. The stock trades at a P/E of 8.9x and an EV/EBITDA of 4.3x — the latter has ticked up around 1% on the week as the price has advanced, but both multiples remain near multi-year lows for the sector. The P/B of 1.28x reflects ongoing buyback activity compressing book value. The dividend yield runs at roughly 3.5% on a forward basis, and the EPS surprise factor score of 80 confirms the company has consistently beaten consensus. With Q3 results pencilled in for 29 October, the next catalyst is roughly ten weeks out — the setup between now and then is primarily about crude price direction and whether the sector's month-long recovery has room to continue or is starting to stretch.
The one institutional angle worth flagging is the flow out of BlackRock, which added nearly 20 million shares through July, and JP Morgan Asset Management, which added another 20 million in the same period. Capital Research also built a significant position — adding 42 million shares through June. These are passive and quasi-passive flows, consistent with index rebalancing and dividend reinvestment at these price levels, but the scale of accumulation into a rising stock is notable context. The question heading into Q3 earnings is whether that pace of institutional absorption continues, or whether the 5% one-month re-rating starts to attract some modest profit-taking ahead of what has historically been a low-volatility print — the last result produced just a 1.8% one-day move.
See the live data behind this article on ORTEX.
Open SHEL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
